PE20000633A1 - Combinaciones terapeuticas para la fragilidad musculoesqueletica - Google Patents

Combinaciones terapeuticas para la fragilidad musculoesqueletica

Info

Publication number
PE20000633A1
PE20000633A1 PE1999000522A PE00052299A PE20000633A1 PE 20000633 A1 PE20000633 A1 PE 20000633A1 PE 1999000522 A PE1999000522 A PE 1999000522A PE 00052299 A PE00052299 A PE 00052299A PE 20000633 A1 PE20000633 A1 PE 20000633A1
Authority
PE
Peru
Prior art keywords
etil
pyridin
oxo
tartrate
salt
Prior art date
Application number
PE1999000522A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
David Duane Thompson
Mei Li
Lydia Codetta Pan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000633A1 publication Critical patent/PE20000633A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE1999000522A 1998-06-16 1999-06-11 Combinaciones terapeuticas para la fragilidad musculoesqueletica PE20000633A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
PE20000633A1 true PE20000633A1 (es) 2000-07-26

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000522A PE20000633A1 (es) 1998-06-16 1999-06-11 Combinaciones terapeuticas para la fragilidad musculoesqueletica

Country Status (29)

Country Link
EP (1) EP1085867A1 (zh)
JP (1) JP2002518328A (zh)
KR (1) KR20010052817A (zh)
CN (1) CN1305378A (zh)
AP (1) AP9901581A0 (zh)
AR (1) AR018868A1 (zh)
AU (1) AU3342099A (zh)
BG (1) BG105128A (zh)
BR (1) BR9911357A (zh)
CA (1) CA2335112A1 (zh)
CO (1) CO5070586A1 (zh)
EA (1) EA200001189A1 (zh)
GT (1) GT199900083A (zh)
HR (1) HRP20000857A2 (zh)
HU (1) HUP0102395A2 (zh)
ID (1) ID26726A (zh)
IL (1) IL139587A0 (zh)
IS (1) IS5727A (zh)
MA (1) MA26648A1 (zh)
NO (1) NO20006381D0 (zh)
OA (1) OA11569A (zh)
PA (1) PA8472101A1 (zh)
PE (1) PE20000633A1 (zh)
PL (1) PL345064A1 (zh)
SK (1) SK18902000A3 (zh)
TN (1) TNSN99118A1 (zh)
UY (1) UY25557A1 (zh)
WO (1) WO1999065488A1 (zh)
ZA (1) ZA993973B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
AU2001276608A1 (en) * 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
JP2005515988A (ja) * 2001-11-29 2005-06-02 ジーティーエックス・インコーポレイテッド 骨粗鬆症を引き起こすアンドロゲン欠乏の予防及び治療
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
IL139587A0 (en) 2002-02-10
CA2335112A1 (en) 1999-12-23
PA8472101A1 (es) 2000-09-29
NO20006381L (no) 2000-12-14
JP2002518328A (ja) 2002-06-25
CN1305378A (zh) 2001-07-25
NO20006381D0 (no) 2000-12-14
AR018868A1 (es) 2001-12-12
HRP20000857A2 (en) 2001-10-31
GT199900083A (es) 2000-12-05
MA26648A1 (fr) 2004-12-20
HUP0102395A2 (hu) 2001-11-28
AP9901581A0 (en) 1999-06-30
EA200001189A1 (ru) 2001-06-25
KR20010052817A (ko) 2001-06-25
SK18902000A3 (sk) 2001-12-03
WO1999065488A1 (en) 1999-12-23
TNSN99118A1 (fr) 2005-11-10
ZA993973B (en) 2000-12-15
ID26726A (id) 2001-02-01
UY25557A1 (es) 2001-01-31
CO5070586A1 (es) 2001-08-28
EP1085867A1 (en) 2001-03-28
IS5727A (is) 2000-11-24
PL345064A1 (en) 2001-11-19
BG105128A (en) 2001-11-30
BR9911357A (pt) 2001-03-13
AU3342099A (en) 2000-01-05
OA11569A (en) 2004-07-01

Similar Documents

Publication Publication Date Title
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
PA8493701A1 (es) Compuestos para tratar la obesidad
BR0100558A (pt) Composições e métodos para tratar a osteoporose
NO20022442L (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ES2267706T3 (es) Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel.
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
BRPI0417621A (pt) terapia de combinação contìnua com agonistas seletivos do receptor ep4 de prostaglandina e um estrogênio para o tratamento de estados que se apresentem com baixa massa óssea
BR0310087A (pt) Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
PE20000644A1 (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
BR0012951A (pt) Agonistas de retinóides seletivos
PE20000633A1 (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
BRPI0409884A (pt) compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BRPI0407178A (pt) Composição farmacêutica osteogênica
BRPI0409818A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
PE20000646A1 (es) Terapia de combinacion para la fragilidad musculoesqueletica
PT1638582E (pt) Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal
BRPI0409881A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR0013582A (pt) Agonistas retinóides seletivos para rar
BR0311371A (pt) Composições para uso terapêutico compreendendo uma vitamina, um sal de metal e insulina ou um hormÈnio de crescimento

Legal Events

Date Code Title Description
FD Application declared void or lapsed